Institutional shares held 31.8 Million
700 calls
500 puts
Total value of holdings $50M
$1K calls
$0 puts
Market Cap $47M
29,529,400 Shares Out.
Institutional ownership 107.82%
# of Institutions 69


Latest Institutional Activity in HOWL

Top Purchases

Q3 2024
Millennium Management LLC Shares Held: 1.32M ($2.1M)
Q3 2024
Northern Trust Corp Shares Held: 228K ($362K)
Q3 2024
Pfm Health Sciences, LP Shares Held: 3.4M ($5.4M)
Q3 2024
Dimensional Fund Advisors LP Shares Held: 258K ($410K)
Q3 2024
Vanguard Group Inc Shares Held: 1.42M ($2.25M)

Top Sells

Q3 2024
Point72 Asset Management, L.P. Shares Held: 110K ($175K)
Q3 2024
Citadel Advisors LLC Shares Held: 11.5K ($18.3K)
Q3 2024
Two Sigma Investments, LP Shares Held: 181K ($287K)
Q3 2024
Bridgeway Capital Management, LLC Shares Held: 88.1K ($140K)
Q3 2024
New York State Common Retirement Fund Shares Held: 5.1K ($8.11K)

About HOWL

Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapeutics engineered to stimulate the body's immune system for the treatment of cancer. The company, through its proprietary PREDATOR platform, designs conditionally activated molecules that stimulate adaptive and innate immunity for addressing the limitations of conventional proinflammatory immune therapies. Its lead product candidates are WTX-124, a conditionally activated Interleukin-2 INDUKINE molecule for the treatment of advanced solid tumors; and WTX-330, a conditionally activated Interleukin-12 INDUKINE molecule for the treatment of relapsed or refractory advanced or metastatic solid tumors or lymphoma. The company is also developing WTX-613, a conditionally activated interferon alpha INDUKINE molecule for the treatment of solid tumors and hematologic malignancies. Werewolf Therapeutics, Inc. was incorporated in 2017 and is headquartered in Cambridge, Massachusetts.


Insider Transactions at HOWL

Insider Transaction List

View all
Date Insider Transaction Ownership Type Shares Traded Value / Price
View All Transactions

Last 12 Months Summary

Buy / Acquisition
0 Shares
From 0 Insiders
Sell / Disposition
0 Shares
From 0 Insiders

Track Institutional and Insider Activities on HOWL

Follow Werewolf Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HOWL shares.

Notify only if

Insider Trading

Get notified when an Werewolf Therapeutics, Inc. insider buys or sells HOWL shares.

Notify only if

News

Receive news related to Werewolf Therapeutics, Inc.

Track Activities on HOWL